Avaliação comparativa da atividade biológica de heparinas não-fracionadas em produtos farmacêuticos

Vaccari, Silvana F; Brum Júnior, Liberato; Masiero, Silvia M. K; Fronza, Marcio; Dalmora, Sérgio L.
Rev. bras. hematol. hemoter ; 25(2): 103-110, abr.-jun. 2003. tab
Artículo en Portugués | LILACS | ID: lil-351827

Documentos relacionados

  1. Chemical sensors for selective and quantitative heparin sensing.
  2. Sulfated Oligomers of Tyrosol: Toward a New Class of Bioinspired Nonsaccharidic Anticoagulants.
  3. Xanthan-Based Materials as a Platform for Heparin Delivery.
  4. Activated Clotting Times Demonstrate Weak Correlation With Heparin Dosing in Adult Extracorporeal Membrane Oxygenation.
  5. Biological and structural analyses of bovine heparin fractions of intermediate and high molecular weight.
  6. An ex vivo comparison of partial thromboplastin time and activated clotting time for heparin anticoagulation in an ovine model.
  7. Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: A multicentre case series of 98 patients.
  8. Evaluation of heparin infusion rates in patients with intravenous drug misuse.
  9. Systematic review of machine learning models for personalised dosing of heparin.
  10. Validation of high concentrated thrombin time assay for unfractionated heparin monitoring.